AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10200010 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol 0.31 mg
Number of subjects: 33
Study 10200010 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol 0.63 mg
Number of subjects: 33
Study 10200010 — intervention group
Group type: EXPERIMENTAL
Intervention: Levalbuterol 1.25 mg
Number of subjects: 33
Study 10200010 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemic albuterol 2.5 mg
Number of subjects: 33
Study 10200010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 7475138 — intervention group
Group type: EXPERIMENTAL
Intervention: Acadesine (0.1 mg/kg per minute intravenous infusion over 7 hours, 5 micrograms/ml in cardioplegic solution)
Number of subjects: 821
Study 7475138 — intervention group
Group type: EXPERIMENTAL
Intervention: Acadesine
Number of subjects: 821
Study 7475138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 821
Study 2324634 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive modeling alone in the use of constraint-seeking questions
Number of subjects: 60
Study 2324634 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive modeling and verbalization in the use of constraint-seeking questions
Number of subjects: 60
Study 313510 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphocyte surface markers combined with Lukes-Collins classification
Number of subjects: 107
Study 30350893 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of breaks in sitting time (classified by tertiles: <26 breaks/h; 26-39 breaks/h; >39 breaks/h)
Number of subjects: 266
Study 28138133 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline free T3
Number of subjects: 569
Study 28138133 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline free T4
Number of subjects: 569
Study 28138133 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in free T3 and total T3 levels
Number of subjects: 569
Study 28138133 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline thyroid hormones
Number of subjects: 569
Study 25968249 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B group (GAL-3 levels)
Number of subjects: 92
Study 25968249 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B group (ALT levels)
Number of subjects: 92
Study 25968249 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B group (GGT levels)
Number of subjects: 92
Study 25968249 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic hepatitis B group (Correlation between GAL-3 and ALT)
Number of subjects: 92
Study 25968249 — intervention group
Group type: COMPARATOR
Intervention: Inactive HBV carriers group (GAL-3 levels)
Number of subjects: 92
Study 25968249 — intervention group
Group type: COMPARATOR
Intervention: Inactive HBV carriers group (ALT levels)
Number of subjects: 92
Study 24046023 — intervention group
Group type: EXPERIMENTAL
Intervention: RPL group
Number of subjects: 68
Study 24046023 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 68
Study 24046023 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational exposure and unhealthy habits
Number of subjects: 68
Study 21527028 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning and problem-solving training
Number of subjects: 89
Study 21527028 — intervention group
Group type: COMPARATOR
Intervention: Basic cognition training
Number of subjects: 89
Study 21527028 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (Planning and problem-solving training and Basic cognition training)
Number of subjects: 89
Study 21527028 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning and problem-solving training and Basic cognition training
Number of subjects: 89
Study 19121589 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH)
Number of subjects: 241
Study 19121589 — intervention group
Group type: COMPARATOR
Intervention: Oral anti-vitamin-K agents (AVK)
Number of subjects: 241
Study 19121589 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (LMWH) in patients with cancer
Number of subjects: 241
Study 19121589 — intervention group
Group type: COMPARATOR
Intervention: Oral anti-vitamin-K agents (AVK) in patients with cancer
Number of subjects: 241
Study 17966026 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (200 mg preoperatively and then twice daily)
Number of subjects: 50
Study 17966026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 17966026 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 50
Study 15017013 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte count
Number of subjects: 18558
Study 15017013 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte count increase over baseline levels
Number of subjects: 18558
Study 11465636 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (n=27)
Number of subjects: 43
Study 11465636 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline (n=16)
Number of subjects: 43
Study 9220235 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15% ganciclovir gel
Number of subjects: 104
Study 9220235 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% ganciclovir gel
Number of subjects: 104
Study 9220235 — intervention group
Group type: COMPARATOR
Intervention: 3% acyclovir ointment
Number of subjects: 104
Study 8285927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 60 mg/d
Number of subjects: 1006
Study 8285927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1006
Study 2821790 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromodeoxyuridine (BUdR) or iododeoxyuridine (IUdR) during high-dose brain irradiation (total radiation dose 65-70 Gy)
Number of subjects: 60
Study 2821790 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who completed planned treatment (48 patients)
Number of subjects: 60
Study 2821790 — intervention group
Group type: COMPARATOR
Intervention: BUdR versus IUdR, 12-h versus 24-h infusion schedule, degree of surgical resection, or sex
Number of subjects: 60
Study 2821790 — intervention group
Group type: EXPERIMENTAL
Intervention: Good performance status and age under 50 years
Number of subjects: 60
Study 31931855 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic Foot Guidance System (SOPeD) - exercises at home three times a week for 12 weeks
Number of subjects: 62
Study 31931855 — intervention group
Group type: COMPARATOR
Intervention: Recommended foot care by international consensus with no foot exercises
Number of subjects: 62
Study 30902613 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib, 600 mg twice daily
Number of subjects: 0
Study 30902613 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib, 250 mg
Number of subjects: 0
Study 30902613 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 0
Study 28335102 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex Paclitaxel Emission Stent (MSCPM-II)
Number of subjects: 72
Study 28335102 — intervention group
Group type: COMPARATOR
Intervention: Covered Metal Stent (CMS)
Number of subjects: 72
Study 25457735 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol 270 (270 mg I/mL), scanned using low tube voltage of 80 kVp, reconstructed with iterative reconstruction techniques (IRT)
Number of subjects: 100
Study 25457735 — intervention group
Group type: COMPARATOR
Intervention: Iopromide 370 (370 mg I/mL), scanned using 100 kVp, reconstructed with filtered back projection
Number of subjects: 100
Study 25457735 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of both groups
Number of subjects: 100
Study 24239203 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel‐eluting balloon (PEB) + self‐expanding nitinol bare‐metal stent (BMS)
Number of subjects: 104
Study 24239203 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) + self‐expanding nitinol bare‐metal stent (BMS)
Number of subjects: 104
Study 24239203 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel‐eluting balloon (PEB) + BMS
Number of subjects: 104
Study 24239203 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA) + BMS
Number of subjects: 104
Study 22000927 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined administration of PYY(3-36) and GLP-1(7-36 amide)
Number of subjects: 0
Study 22000927 — intervention group
Group type: COMPARATOR
Intervention: Physiological effects following a meal
Number of subjects: 0
Study 19891258 — intervention group
Group type: EXPERIMENTAL
Intervention: GaAIAS (780 nm) laser, applied in continuous mode, twice a week, for four weeks, with energy set to 25 J/cm2.
Number of subjects: 60
Study 19891258 — intervention group
Group type: EXPERIMENTAL
Intervention: GaAIAS (780 nm) laser, applied in continuous mode, twice a week, for four weeks, with energy set to 60 J/cm2.
Number of subjects: 60
Study 19891258 — intervention group
Group type: EXPERIMENTAL
Intervention: GaAIAS (780 nm) laser, applied in continuous mode, twice a week, for four weeks, with energy set to 105 J/cm2.
Number of subjects: 60
Study 19891258 — intervention group
Group type: COMPARATOR
Intervention: Placebo applications simulating the same parameters as the treated groups.
Number of subjects: 60
Study 16489525 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin infusion (40 microg/ml, 2.5 ml/min for 60 minutes)
Number of subjects: 6
Study 16489525 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical distension
Number of subjects: 6
Study 16489525 — intervention group
Group type: COMPARATOR
Intervention: Control group (6 volunteers; 3 women; age 27.5 ± 5.9 years)
Number of subjects: 6
Study 15486846 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated hepatitis A vaccine (VAQTA; Merck), administered at weeks 0 and 24
Number of subjects: 90
Study 15486846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 10650680 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training intervention utilizing elastic bands for 8 weeks
Number of subjects: 62
Study 10650680 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study 8873668 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin therapy
Number of subjects: 819
Study 8873668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 819
Study 1403211 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 62
Study 1403211 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine/naltrexone
Number of subjects: 62
Study 1403211 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 62
Study 6365849 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin supplement (15 mg)
Number of subjects: 37
Study 6365849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 30761648 — intervention group
Group type: EXPERIMENTAL
Intervention: MyCognition Quotient (MyCQ)
Number of subjects: 87
Study 30761648 — intervention group
Group type: COMPARATOR
Intervention: Cambridge Neuropsychological Automated Test Battery (CANTAB)
Number of subjects: 87
Study 28335758 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health First Aid (MHFA) course for nursing students
Number of subjects: 181
Study 25888158 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive bias modification (CBM) training with motivational support (MS)
Number of subjects: 120
Study 23429175 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic field real‐time system (EFRTS)
Number of subjects: 48
Study 23429175 — intervention group
Group type: COMPARATOR
Intervention: Freehand technique
Number of subjects: 48
Study 20980720 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocoagulation-enabled biopsy (EC+ group)
Number of subjects: 160
Study 20980720 — intervention group
Group type: COMPARATOR
Intervention: Conventional biopsy without electrocoagulation (EC- group)
Number of subjects: 160
Study 19319449 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified human milk
Number of subjects: 40
Study 19319449 — intervention group
Group type: COMPARATOR
Intervention: Human milk
Number of subjects: 40
Study 17275926 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate (1g solution, swished and swallowed four times daily for 7 days)
Number of subjects: 58
Study 17275926 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (1g solution, swished and swallowed four times daily for 7 days)
Number of subjects: 58
Study 15534122 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical removal
Number of subjects: 225
Study 15534122 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 225
Study 15534122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 225
Study 12811010 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin
Number of subjects: 0
Study 12811010 — intervention group
Group type: EXPERIMENTAL
Intervention: Argatroban
Number of subjects: 0
Study 10344012 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy; specific details on dosage and duration not available
Number of subjects: 0
Study 10344012 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 7562419 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 10 U/kg i.v. bolus dose
Number of subjects: 10
Study 7562419 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 100 U/kg i.v. bolus dose
Number of subjects: 10
Study 7562419 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (Epo) 500 U/kg i.v. bolus dose
Number of subjects: 10
Study 2123240 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 89
Study 2123240 — intervention group
Group type: COMPARATOR
Intervention: Penicillin
Number of subjects: 89
Study 2123240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 89
Study 7393824 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 0
Study 7393824 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmethylclomipramine
Number of subjects: 0
Study 7393824 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine and desmethylclomipramine
Number of subjects: 0
Study 6541546 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise
Number of subjects: 23
Study 6541546 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic exercise
Number of subjects: 23
Study 30205241 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium reduction to <1500 mg daily counseling
Number of subjects: 0
Study 30205241 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 27333897 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral (CB) depression prevention group
Number of subjects: 119
Study 27333897 — intervention group
Group type: COMPARATOR
Intervention: Health education (HE) control group
Number of subjects: 119
Study 24890531 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldosterone blockade
Number of subjects: 41
Study 24890531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 22976626 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary alveolar bone grafting (SABG) during mixed dentition (n = 16)
Number of subjects: 31
Study 22976626 — intervention group
Group type: COMPARATOR
Intervention: Tertiary alveolar bone grafting (TABG) during permanent dentition (n = 15)
Number of subjects: 31
Study 20427052 — intervention group
Group type: EXPERIMENTAL
Intervention: Competent model
Number of subjects: 0
Study 20427052 — intervention group
Group type: COMPARATOR
Intervention: Incompetent model
Number of subjects: 0
Study 18551008 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate controlled 12 week exercise program (arm-cycling at target lactate concentrations of 2.0 +/- 0.5 mmol/l)
Number of subjects: 24
Study 18551008 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activity (control group)
Number of subjects: 24
Study 15786889 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT) with TST screening
Number of subjects: 914
Study 15786889 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid preventive therapy (IPT) without TST screening
Number of subjects: 914
Study 12875311 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-fit compression shorts
Number of subjects: 20
Study 10595329 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens
Number of subjects: 103
Study 10595329 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous conjugated equine estrogens + progestin
Number of subjects: 103
Study 10595329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 7566901 — intervention group
Group type: EXPERIMENTAL
Intervention: Small circular cosine grating with randomized location embedded in spatial noise, exposed for 33 to 533 ms in peripheral vision.
Number of subjects: 0
Study 7566901 — intervention group
Group type: EXPERIMENTAL
Intervention: Foveal search task with free eye movements and unlimited exposure time, with and without noise.
Number of subjects: 0
Study 7566901 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical cosine grating exposed for 500 ms, varying randomization range of aperture orientation in the fovea with and without noise.
Number of subjects: 0
Study 1718476 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 30
Study 1718476 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 30
Study 7080502 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbodorsal technique of tumour nephrectomy
Number of subjects: 51
Study 7080502 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperitoneal technique of tumour nephrectomy
Number of subjects: 51
Study 31714586 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-2206 200 mg weekly (initial dose), reduced to 135 mg due to toxicity
Number of subjects: 37
Study 31270967 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron administration
Number of subjects: 32
Study 31270967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 27392481 — intervention group
Group type: EXPERIMENTAL
Intervention: CM plus WM therapy (Reduning Injection or Xiyanping Injection)
Number of subjects: 451
Study 27392481 — intervention group
Group type: COMPARATOR
Intervention: WM therapy alone
Number of subjects: 451
Study 27453366 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary pepsin measurement
Number of subjects: 50
Study 24779746 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentures with reduced dental arches (WSM)
Number of subjects: 20
Study 24779746 — intervention group
Group type: COMPARATOR
Intervention: Dentures with full dental arches (FDA)
Number of subjects: 20
Study 24779746 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentures with reduced dental arches (WSM) after adding second molars
Number of subjects: 20
Study 24779746 — intervention group
Group type: COMPARATOR
Intervention: Dentures with full dental arches (FDA) after removing second molars
Number of subjects: 20
Study 22297674 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg elemental calcium diet
Number of subjects: 0
Study 22297674 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 mg elemental calcium diet
Number of subjects: 0
Study 22297674 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased calcium intake
Number of subjects: 0
Study 19664081 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Care Planning (MCP)
Number of subjects: 49
Study 19664081 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 49
Study 17453536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac deaths < or =30 days
Number of subjects: 302
Study 17453536 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cardiac deaths < or =30 days
Number of subjects: 302
Study 17453536 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital deaths >30 days
Number of subjects: 302
Study 17453536 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivors of initial hospitalization
Number of subjects: 302
Study 17453536 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic vascular resistance index among deaths < or =30 days
Number of subjects: 302
Study 15177809 — intervention group
Group type: EXPERIMENTAL
Intervention: Bakker's Hemisphere-Specific Stimulation (n = 9)
Number of subjects: 30
Study 15177809 — intervention group
Group type: EXPERIMENTAL
Intervention: Random presentation of stimuli in either visual hemifield (n = 7)
Number of subjects: 30
Study 15177809 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrally presented stimuli (n = 8)
Number of subjects: 30
Study 15177809 — intervention group
Group type: EXPERIMENTAL
Intervention: Central stimuli with fixed presentation time (1500 ms) (n = 6)
Number of subjects: 30
Study 11346139 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate-based triple therapy (RAM group)
Number of subjects: 59
Study 11346139 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole-based triple therapy (OAM group)
Number of subjects: 59
Study 11346139 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RAM and OAM groups
Number of subjects: 59
Study 9927810 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of beta 2-glycoprotein I (GPI) to sera from lepromatous leprosy patients
Number of subjects: 140
Study 9927810 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of beta 2-glycoprotein I (GPI) to sera from borderline leprosy patients
Number of subjects: 140
Study 9927810 — intervention group
Group type: COMPARATOR
Intervention: Comparison of aCL titres in skin smear positive vs bacteriologically negative patients
Number of subjects: 140
Study 7922637 — intervention group
Group type: EXPERIMENTAL
Intervention: Static electromagnetic field stimulation of 12.5 mT, single stimulation for 3x3 minutes with one minute breaks.
Number of subjects: 119
Study 7922637 — intervention group
Group type: EXPERIMENTAL
Intervention: Static electromagnetic field stimulation (in stimulated group)
Number of subjects: 119
Study 7922637 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated stimulation of static electromagnetic field
Number of subjects: 119
Study 3147895 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen pressure measurements during oxygen breathing (5 and 10 1 O2 min‐1)
Number of subjects: 76